Aditya Birla Sun Life Pharma & Healthcare Fund Growth Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

Aditya Birla Sun Life Pharma & Healthcare Fund Growth Fund Overview

Min. investment

SIP ₹100 & Lump. ₹1000

AUM (Fund size)

901 Cr

Lock In Period

N/A

Expense Ratio

2.27

Exit Load

For redemption/switchout of units on or before 30 days from the date of allotment: 1.00% of applicable NAV. For redemption/switch-out of units after 30 days from the date of allotment: Nil.

Benchmark

BSE Healthcare Total Return

Summary

Aditya Birla Sun Life Pharma & Healthcare Fund Growth NAV is ₹33. as of 5 Jun, 2026. Aditya Birla Sun Life Pharma & Healthcare Fund Growth has delivered 86.09% returns since its launch. The minimum SIP investment amount in Aditya Birla Sun Life Pharma & Healthcare Fund Growth is ₹100. The AUM of Aditya Birla Sun Life Pharma & Healthcare Fund Growth is ₹901 Cr. The expense ratio of the fund is 2.27%, and its benchmark is BSE Healthcare Total Return. The current exit load of the fund is For redemption/switchout of units on or before 30 days from the date of allotment: 1.00% of applicable NAV. For redemption/switch-out of units after 30 days from the date of allotment: Nil.. In the last 1M months, Aditya Birla Sun Life Pharma & Healthcare Fund Growth has delivered 4.14% returns.

Aditya Birla Sun Life Pharma & Healthcare Fund Growth Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M4.140.174.98
6M6.641.588.52
1Y10.624.8114.61
3Y23.0014.41106.23

Portfolio Analysis

  • Equity: 98.61%
  • Debt: 1.40%
  • Others
As on: 2026-04-30
View allocation % by

1. Sun Pharmaceutical Industries Limited13.17%
2. Torrent Pharmaceuticals Limited4.76%
3. J.B. Chemicals & Pharmaceuticals Limited4.71%
4. Aurobindo Pharma Limited4.49%
5. Ajanta Pharmaceuticals Limited4.05%
6. Lupin Limited4.00%
7. Mankind Pharma Ltd3.88%
8. Abbott India Limited3.65%
9. Emcure Pharmaceuticals Ltd3.32%
10. Cipla Limited3.30%
11. IPCA Laboratories Limited2.86%
12. Shilpa Medicare Ltd2.51%
13. CORONA Remedies Ltd2.24%
14. SAI Life Sciences Ltd2.20%
15. Alkem Laboratories Limited2.10%
16. Procter & Gamble Health Limited2.04%
17. Divi's Laboratories Limited1.88%
18. Dr. Reddys Laboratories Limited1.45%
19. ALEMBIC PHARMACEUTICALS LIMITED1.35%
20. Pfizer Limited1.34%
21. Jubilant Pharmova Ltd1.20%
22. ANTHEM BIOSCIENCES LIMITED1.20%
23. Biocon Limited1.08%
24. Piramal Pharma Ltd1.04%
25. Gland Pharma Limited0.97%
26. GlaxoSmithKline Pharmaceuticals Limited0.85%

1. Apollo Hospitals Enterprise Limited7.20%
2. Fortis Healthcare Limited3.87%
3. Jupiter Life Line Hospitals Ltd1.79%
4. Thyrocare Technologies Limited1.58%
5. METROPOLIS HEALTHCARE LIMITED1.42%
6. Suraksha Diagnostic Ltd1.06%
7. Vijaya Diagnostic Centre Limited0.98%
8. Dr. Lal Path Labs Limited0.94%
9. Max Healthcare Institute Limited0.77%

1. SANOFI CONSUMER HEALTHCARE1.67%

About Fund Aditya Birla Sun Life Pharma & Healthcare Fund Growth

Aditya Birla Sun Life Pharma & Healthcare Fund Growth managed by Aditya Birla Sun Life Mutual Fund,is a Healthcare & Pharmascheme with Assets Under Management of ₹901 Crore. The fund benchmarks its performance against the BSE Healthcare Total Return while maintaining an expense ratio of 2.27. Under the expert guidance of Dhaval Shah ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Fund Managers

Dhaval Shah

Mr. Dhaval Shah holds B.Com, CFA, MMS - Finance (Post graduation). He has worked with Morgan Stanley Investment Management, Reliance Capital Asset Management Ltd. and Edelweiss Securities.

Peer Comparison

Fund Name1Y3Y
This FundTata India Pharma & HealthCare Fund Growth5.825279.8688
This FundLIC MF Healthcare Fund Growth8.194680.1468
This FundAditya Birla Sun Life Pharma & Healthcare Fund Growth10.618386.0938
This FundUTI Healthcare Fund Growth9.883398.0883
This FundICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth6.5104101.0816

Aditya Birla Sun Life Pharma & Healthcare Fund Growth FAQs

Aditya Birla Sun Life Pharma & Healthcare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of Aditya Birla Sun Life Pharma & Healthcare Fund Growth is 2.27. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

Aditya Birla Sun Life Pharma & Healthcare Fund Growth’s fund performance is as follows:
  • 1 Month : 4.14%
  • 6 Months : 6.64%
  • 1 Year : 10.62%
  • 3 Years : 23.00%
Returns of Aditya Birla Sun Life Pharma & Healthcare Fund Growth are updated daily based on NAV of ₹ 33. as on Jun 04,2026. Since inception, the return has been 86.09%.

You can invest in Aditya Birla Sun Life Pharma & Healthcare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of Aditya Birla Sun Life Pharma & Healthcare Fund Growth is ₹901 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in Aditya Birla Sun Life Pharma & Healthcare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.